Drug Approval | April 23, 2025
A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
Expanding US operations to address the increased demand for API development and manufacturing
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Subscribe To Our Newsletter & Stay Updated
